Member Info for missthepenny62

Listen to the interview and top up. Agree Rebarn, an academia based scientist should not word these RNSs. Their broker shouldn't have let them.

According to Cath, the freeze dried powder is what they'll be selling. The cream w the 24 hr issue is just for the trial only and NOT for commercialisation.

SHOULD'VE SAID THAT IN THE RNS!

Buy opp for those not in yet, trial very soon, only takes a month and will be worth $$$$$

GLA!

You're not the only one, but it doesn't feel too risky at this price considering the first time I bought 10000 KENV shares it cost me £1400!!! So I just got a 90% discount on the same amount thanks to GC's misinformation (or rather I paid a 90% premium bcos of it the first time round!).

Drill results had better be good because like a few others here I'm so underwater I'm basically in the Mariana Trench and it's been absolutely ruinous. However, I haven't given up hope yet... The stuff is in the ground, the rest is up to LJ et al.

GLA!

threshold crossed yday. no prizes for guessing who the £3.5m trade was then...

These AT trades are driving me mad and must be avenged! Anyway, in the meantime, we're still at 100m mcap and now with a 95%+ chance of becoming a £bn+ company from just 6 months onwards. Insane:

https://twitter.com/missthepenny62/status/1029392829267623936

They state that their drug was just as effective as the far more harmful steroid equivalent, however so was the placebo - it's IMM all over again! They still have a 'cure' for acne in the pipeline but let's see what happens with that and their other drug once they review all their data. As you say, cashed up, and they certainly recovered well from the last P2 failure (last chance saloon surely now but I believe that to be priced in at this level). A small punt might not be such a bad idea.

They so have a new twitter account: https://mobile.twitter.com/KazeraPlc

Or even possibly trading against themselves to keep the SP range bound in order to launch a lowball offer after NDA? Stranger things have happened! I remember a poster here saying ages ago that any takeover would most likely happen between NDA and FDA decisions. Makes sense, as derisked as it's going to get post-NDA and as cheap as it's going to be pre-FDA. Just a theory but still possible.

Thanks Ivy have just tweeted accordingly. The manipulation on this share has driven me mad but it's still my largest holding by a distance. Am hoping the ATs will finally stop on NDA acceptance. Surely whoever's been holding it down will want it to go up eventually!! :-/

Well done, excellent opportunity on this dip I believe. People panicking and profit taking but with big news so close it will rise through the 20s again IMO, and beyond that we will see a serious rerate provided the trial goes as planned. The fact they've already stated they haven't lost efficacy after scale up is a positive indicator. The trial is relatively cheap, short, and they already have a major player who have paid for the privilege to be waiting in the wings. GLA.

Three buys and a sell, all listed as sells, for a grand total of around two grand, and the SP drops 7%. Nuts.

No idea how the sp just dropped on that statement, all looking good and could be massive if things go as expected / hoped at year end. Maybe it's just impatient sellers. Expect another substantial rise towards Xmas...

Ridiculously cheap now.

Excellent stuff Pearo, thanks for that.

Incidentally my buy today was listed as a sell and judging by the price action there were a few other similar cases.

Given what we presently know about the company I'm somewhat perplexed with regard to today's drop in the SP to an ATL.

They are now making actual profit from their research business, their NAV continues to increase above and beyond the macp, they have zero debt.

Finncap, one of the more respected houses, are now their broker, whom they apparently claim are going to help with IPOs of some of their projects as opposed to an overall placing. Lucyd, with it's 'next big thing' potential of patented AR glasses (tbf they do look amazing), launches in just a couple of weeks. Their 'Neosnax' miracle salt is supposedly teaming up with a world leading snack brand, and Belluscura have a good near term pipeline, and their other projects are all stringently selected disruptive tech.

What I like most though is their overall model. They essentially have first dibs on low cost, high potential IPs as soon as they become 'available' from the world's leading Universities.

LTH for me but still disappointed to see it down here. Some PIs whose opinions I respect are blaming a seller all the way down from 35p and I'm inclined to agree with them. Once the round sells disappear it could recover very quickly, and if it drops any lower I'll be obliged to average down!

GLA.

After the recent sp crashes in other pharmas due to failed trials, SALV is fast becoming my favorite pharma thanks to the fact it follows a venture capital / investment fund model. Lower risk but still with massive potential rewards. It is to pharma what reabold is to O&G and I'm in both for that reason! Recent rise indicates sthg is afoot but I'm in for the long haul either way, as are the key investors backing the project...

Interview - 'A tremendously exciting time... A revenue generating company going forward' (they needed a new CFO given the recent mess, IMO):

https://www.youtube.com/watch?v=DfMmexKWfdQ

The most positive and bullish RNS I can recall from a company that is trading near ATLs. The mcap is still at cash level, but now the science is no longer considered worthless (by any means) - things are finally coming to fruition, though it has a long way to go for some LTHs here to recover their initial investments I know...

You'd think after the recent crashes in IMM SUMM N4P etc due to failed trials, that PIs would be loading up on Motif!

It's the only AIM co I know of that is currently sitting on successful Phase 3 data and the SP has barely budged a penny. There's definitely sthg fishy with the manipulation here but am going to ride it out all the way to the 90+% CoS of approval.

Dips like today may well be designed to trick weak hands. I honestly can't see any other reason for it but then WDIK?

GLA.

Good to see plans to roll out 'Teethcells' soon - I assume this is their INDUS technology and a key reason I initially invested.

Would be risky to sell before Sep 30, IMO. Profit is profit but am too curious to see what the preferred buyout offer will be.